DigestRedComo funciona
Red
/
Empresas
Pr
No verificado

Prolong Pharmaceuticals, LLC

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa
30/04/2026
Industria
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Prolong’s Investigational Therapy for Acute Ischemic Stroke, PP-007, Receives FDA Breakthrough Therapy Designation
Fuente
Prolong Pharmaceuticals, LLC
Editor
Business Wire
1.00
0
05/02/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
Prolong Pharmaceuticals to Present Preliminary Phase 1 Data from HEMERA-1 for PP-007 in Acute Ischemic Stroke (AIS) at the 2025 International Stroke Conference (ISC)
Fuente
Prolong Pharmaceuticals, LLC
Editor
Business Wire
1.00
0
13/11/2024
Eventos
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Prolong Pharmaceuticals to Present Clinical Data regarding PP-007, PEGylated carboxyhemoglobin bovine product, at the 2024 International Symposium on Blood Substitutes (ISBS)
Fuente
Prolong Pharmaceuticals, LLC
Editor
Business Wire
1.00
0
30/10/2024
Industria
Ciencia
Higiene alimentaria
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
U.S. Food and Drug Administration (FDA) Grants Prolong Pharmaceuticals FDA Fast Track Designation for Novel Stroke Therapy (PP-007) in HEMERA-1 Clinical Study
Fuente
Prolong Pharmaceuticals, LLC
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0